SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20413772
Source:
http://linkedlifedata.com/resource/pubmed/id/20413772
Search
Subject
(
85
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0013216
,
umls-concept:C0017636
,
umls-concept:C0025663
,
umls-concept:C0031001
,
umls-concept:C0596087
,
umls-concept:C0871261
,
umls-concept:C1704632
,
umls-concept:C1706817
,
umls-concept:C2603343
,
umls-concept:C2911692
pubmed:issue
2
pubmed:dateCreated
2010-4-23
pubmed:abstractText
To derive a magnetic resonance (MR)-based imaging metric that reflects local perfusion changes resulting from the administration of angiogenic-inhibiting chemotherapy in patients with recurrent glioblastoma multiforme (GBM).
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/R01 NS049395-04
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-12663823
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-14625221
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-15140713
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-15502131
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-15627003
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-15709123
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-15906288
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-16396838
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-16611778
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-16611779
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-17222792
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-17416835
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-17969025
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-1812360
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-1881317
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-19377487
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-19549889
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-2345506
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-2358840
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-8946351
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20413772-9345556
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401260
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized
,
http://linkedlifedata.com/resource/pubmed/chemical/Contrast Media
,
http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1527-1315
pubmed:author
pubmed-author:CarrollTimothy JTJ
,
pubmed-author:ChandlerJames PJP
,
pubmed-author:GetchChristopherC
,
pubmed-author:GrimmSean ASA
,
pubmed-author:HorowitzSandra WSW
,
pubmed-author:LevyRobertR
,
pubmed-author:RaizerJeffreyJ
,
pubmed-author:SawlaniRahul NRN
,
pubmed-author:ShinWanyongW
pubmed:issnType
Electronic
pubmed:volume
255
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
622-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20413772-Angiogenesis Inhibitors
,
pubmed-meshheading:20413772-Antibodies, Monoclonal
,
pubmed-meshheading:20413772-Antibodies, Monoclonal, Humanized
,
pubmed-meshheading:20413772-Brain Neoplasms
,
pubmed-meshheading:20413772-Contrast Media
,
pubmed-meshheading:20413772-Disease Progression
,
pubmed-meshheading:20413772-Drug Administration Schedule
,
pubmed-meshheading:20413772-Female
,
pubmed-meshheading:20413772-Glioblastoma
,
pubmed-meshheading:20413772-Humans
,
pubmed-meshheading:20413772-Image Processing, Computer-Assisted
,
pubmed-meshheading:20413772-Magnetic Resonance Angiography
,
pubmed-meshheading:20413772-Male
,
pubmed-meshheading:20413772-Middle Aged
,
pubmed-meshheading:20413772-Neovascularization, Pathologic
,
pubmed-meshheading:20413772-Pilot Projects
,
pubmed-meshheading:20413772-Predictive Value of Tests
,
pubmed-meshheading:20413772-Proportional Hazards Models
,
pubmed-meshheading:20413772-Retrospective Studies
pubmed:year
2010
pubmed:articleTitle
Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study.
pubmed:affiliation
Department of Radiology, Northwestern University, 737 N Michigan Ave, 16th Floor, Chicago, IL 60611, USA.
pubmed:publicationType
Journal Article